Table 2.
Early outcomes and chemotherapy after gastrojejunostomy and palliative gastrectomy
| Gastrojejunostomy | Gastrectomy | P value | |
|---|---|---|---|
| (n = 25) | (n = 18) | ||
| Operative time (min) | 165 (102–365) | 189 (94–364) | 0.08 |
| Intraoperative blood loss (mL) | 86 (0–950) | 215 (42–790) | 0.02 |
| ΔGOOSS | |||
| Median (range) | 2 (0–3) | 1 (-2–3) | 0.13 |
| Morbidity | 8 | 2 | 0.10 |
| Anastomotic stricture | 2 | 0 | |
| Anastomotic leakage | 0 | 0 | |
| Anorexia | 2 | 1 | |
| Catheter infection | 3 | 0 | |
| Others | 1 | 1 | |
| Number of patients given postoperative chemotherapy | 19 | 15 | 0.56 |
| Regimens | |||
| S-1 | 6 | 5 | |
| S-1 + CDDP | 13 | 6 | |
| S-1 + Taxane(DTX/PTX) | 0 | 2 | |
| Other | 0 | 2 |
CDDP, Cisplatin; DTX, Docetaxel; GOOSS, Gastric outlet obstruction scoring system; PTX, Paclitaxel.